1. Home
  2. CLIR vs CASI Comparison

CLIR vs CASI Comparison

Compare CLIR & CASI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CLIR
  • CASI
  • Stock Information
  • Founded
  • CLIR 2008
  • CASI 1991
  • Country
  • CLIR United States
  • CASI China
  • Employees
  • CLIR N/A
  • CASI N/A
  • Industry
  • CLIR Industrial Machinery/Components
  • CASI Biotechnology: Pharmaceutical Preparations
  • Sector
  • CLIR Industrials
  • CASI Health Care
  • Exchange
  • CLIR Nasdaq
  • CASI Nasdaq
  • Market Cap
  • CLIR 59.3M
  • CASI 58.8M
  • IPO Year
  • CLIR 2012
  • CASI 1996
  • Fundamental
  • Price
  • CLIR $1.18
  • CASI $2.63
  • Analyst Decision
  • CLIR Strong Buy
  • CASI Strong Buy
  • Analyst Count
  • CLIR 1
  • CASI 1
  • Target Price
  • CLIR $6.00
  • CASI $6.00
  • AVG Volume (30 Days)
  • CLIR 133.1K
  • CASI 26.3K
  • Earning Date
  • CLIR 03-31-2025
  • CASI 03-27-2025
  • Dividend Yield
  • CLIR N/A
  • CASI N/A
  • EPS Growth
  • CLIR N/A
  • CASI N/A
  • EPS
  • CLIR N/A
  • CASI N/A
  • Revenue
  • CLIR $4,280,000.00
  • CASI $22,055,000.00
  • Revenue This Year
  • CLIR $69.16
  • CASI N/A
  • Revenue Next Year
  • CLIR $440.76
  • CASI $134.79
  • P/E Ratio
  • CLIR N/A
  • CASI N/A
  • Revenue Growth
  • CLIR 263.02
  • CASI N/A
  • 52 Week Low
  • CLIR $0.62
  • CASI $2.05
  • 52 Week High
  • CLIR $1.72
  • CASI $7.67
  • Technical
  • Relative Strength Index (RSI)
  • CLIR 48.40
  • CASI 36.60
  • Support Level
  • CLIR $1.14
  • CASI $2.30
  • Resistance Level
  • CLIR $1.40
  • CASI $2.58
  • Average True Range (ATR)
  • CLIR 0.13
  • CASI 0.23
  • MACD
  • CLIR -0.02
  • CASI 0.03
  • Stochastic Oscillator
  • CLIR 24.53
  • CASI 18.64

About CLIR ClearSign Technologies Corporation (DE)

ClearSign Technologies Corp is engaged in providing solutions to some of the pressing productivity, energy efficiency, and pollution problems affecting the energy, oil, and gas production, boiler, and processing industries. It believes that its patented ClearSign Core technology can enhance the performance of combustion systems in a broad range of markets, including the energy (upstream oil production and downstream refining), institutional, commercial, and industrial boiler, chemical, and petrochemical industries. The company offers products that include process burners, boiler burners, flares, and ClearSign Eye.

About CASI CASI Pharmaceuticals Inc.

CASI Pharmaceuticals Inc is a biopharmaceutical company that focuses on commercializing therapeutics and pharmaceutical products. The products include injections for patients who are suffering from leukemias and lymphomas. The EVOMELA injection is used as a conditioning treatment before autologous stem cell transplant for patients with multiple myeloma. The company products include CID-103, CNCT19, EVOMELA, MARQIBO, ZEVALIN, ENMD-2076 and others. The majority of the revenue is generated from the product sales of EVOMELA.

Share on Social Networks: